MedPath

Prevention of Postpartum Haemorrhage

Not Applicable
Conditions
Post Partum Hemorrhage
Interventions
Registration Number
NCT04463966
Lead Sponsor
Benha University
Brief Summary

Use of Tranexamic Acid for prevention of Postpartum hemorrhage in high risk patients: Randomized Control Trial

Detailed Description

This study aims to assess the efficacy of administration of Tranexamic Acid in preventing Postpartum haemorrhage \& reducing intraoperative and postoperative blood loss in high risk women for Postpartum Hemorrhage undergoing caesarean section. Studying its benefit to transfusion-sparing and hysterectomy-sparing. \& reduction of hemorrhage-related mortality when Postpartum hemorrhage is expected.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Women at high risk for postpartum hemorrhage after cesarean section
Exclusion Criteria
  • women who are not at high risk for postpartum hemorrhage , or attending for normal vaginal delivery.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
StudyTranexamic acid injectionTranexamic acid 1 gm (100 mg/ml) slowly intravenous infusion during delivery ( administered over 10 minutes at 1 ml/minute) .
Primary Outcome Measures
NameTimeMethod
blood lossimmediately after deliver

Estimation of blood loss

Secondary Outcome Measures
NameTimeMethod
blood pressureimmediately after delivery

blood pressure

pulseimmediately after delivery

pulse

temperatureimmeditely after delivery

temperature

Trial Locations

Locations (1)

Police Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath